BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND STAT5B, STAT5, 6777, ENSG00000173757, P51692 AND Prognosis
40 results:

  • 1. The novel TERF2::PDGFRB fusion gene enhances tumorigenesis via PDGFRB/stat5 signalling pathways and sensitivity to TKI in ph-like ALL.
    Xu GF; Zeng Z; Zhang ZB; Zhang XM; Wang M; Xiao Q; Li J; Xie XQ; He S; Fu HH; Liu Y; Yang ZL; Chen Y; Shi J; Wang B; Qiu HY; Zhou Q; Liu Y; Chen SN
    J Cell Mol Med; 2024 Feb; 28(3):e18114. PubMed ID: 38323741
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. XBP1 promotes NRAS
    Salimi A; Schemionek-Reinders M; Huber M; Vieri M; Patterson JB; Alten J; Brümmendorf TH; Kharabi Masouleh B; Appelmann I
    J Cell Mol Med; 2023 Nov; 27(21):3363-3377. PubMed ID: 37753803
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Higher 13-Gene-Estimated TMB Detected from Plasma ctDNA is Associated with Worse Outcome for T-Cell lymphoma Patients.
    Chen C; Huang L; Chen Z; Ou Q; Liu S; Jiang X; Chen F; Wei X; Guo H; Shao Y; Zeng C; Li Y; Li W
    Adv Biol (Weinh); 2023 Dec; 7(12):e2300042. PubMed ID: 37658484
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The genetic polymorphisms of immune-related genes contribute to the susceptibility and survival of lymphoma.
    Gu C; Can C; Liu J; Wei Y; Yang X; Guo X; Wang R; Jia W; Liu W; Ma D
    Cancer Med; 2023 Jul; 12(14):14960-14978. PubMed ID: 37329186
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. IL-2/IL-2R signaling and IL-2Rα-targeted therapy in anaplastic large cell lymphoma.
    Liang HC
    Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):25-30. PubMed ID: 36094651
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphoma.
    Lind J; Hellinger R; Kudweis P; Moll HP; Gattringer J; Thell K; Edtmayer S; Gruber CW; Stoiber D; Kollmann K
    Biomed Pharmacother; 2022 Sep; 153():113486. PubMed ID: 36076504
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Recent research on the association between signal transducer and activator of transcription 5 and childhood acute lymphoblastic leukemia.
    Duan YF; Wen FQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Aug; 24(8):942-947. PubMed ID: 36036135
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Phenotype, Function, and Clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone lymphoma.
    Tang X; Yang ZZ; Kim HJ; Anagnostou T; Yu Y; Wu X; Chen J; Krull JE; Wenzl K; Mondello P; Bhardwaj V; Wang J; Novak AJ; Ansell SM
    Clin Cancer Res; 2022 Oct; 28(19):4322-4335. PubMed ID: 35686915
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma.
    Liang HC; Costanza M; Prutsch N; Zimmerman MW; Gurnhofer E; Montes-Mojarro IA; Abraham BJ; Prokoph N; Stoiber S; Tangermann S; Lobello C; Oppelt J; Anagnostopoulos I; Hielscher T; Pervez S; Klapper W; Zammarchi F; Silva DA; Garcia KC; Baker D; Janz M; Schleussner N; Fend F; Pospíšilová Š; Janiková A; Wallwitz J; Stoiber D; Simonitsch-Klupp I; Cerroni L; Pileri S; de Leval L; Sibon D; Fataccioli V; Gaulard P; Assaf C; Knörr F; Damm-Welk C; Woessmann W; Turner SD; Look AT; Mathas S; Kenner L; Merkel O
    Nat Commun; 2021 Sep; 12(1):5577. PubMed ID: 34552066
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Therapeutic delivery of siRNA with polymeric carriers to down-regulate stat5A expression in high-risk B-cell acute lymphoblastic leukemia (B-ALL).
    Mohseni M; Kucharski C; K C RB; Nasrullah M; Jiang X; Uludağ H; Brandwein J
    PLoS One; 2021; 16(6):e0251719. PubMed ID: 34157051
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK + LBCL): a systematic review of clinicopathological features and management.
    Castillo JJ; Beltran BE; Malpica L; Marques-Piubelli ML; Miranda RN
    Leuk Lymphoma; 2021 Dec; 62(12):2845-2853. PubMed ID: 34151703
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Jak-STAT Inhibition Mediates Romidepsin and Mechlorethamine Synergism in Cutaneous T-Cell lymphoma.
    Cortes JR; Patrone CC; Quinn SA; Gu Y; Sanchez-Martin M; Mackey A; Cooke AJ; Shih BB; Laurent AP; Trager MH; Ferrando AA; Geskin LJ; Palomero T
    J Invest Dermatol; 2021 Dec; 141(12):2908-2920.e7. PubMed ID: 34089720
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The delta isoform of phosphatidylinositol-3-kinase predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinib.
    Villaume MT; Arrate MP; Ramsey HE; Sunthankar KI; Jenkins MT; Moyo TK; Smith BN; Fischer MA; Childress MA; Gorska AE; Ferrell PB; Savona MR
    Exp Hematol; 2021 May; 97():57-65.e5. PubMed ID: 33617893
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Novel cytokine-antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma.
    Chu Y; Nayyar G; Kham Su N; Rosenblum JM; Soon-Shiong P; Lee J; Safrit JT; Barth M; Lee D; Cairo MS
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33109629
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Silencing Stat3 inhibits viability and induces apoptosis in BGC-823 human gastric cancer cell line.
    Xu Y; Feng S; Niu B
    Biotech Histochem; 2021 Jan; 96(1):76-81. PubMed ID: 32619110
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome.
    Willerslev-Olsen A; Buus TB; Nastasi C; Blümel E; Gluud M; Bonefeld CM; Geisler C; Lindahl LM; Vermeer M; Wasik MA; Iversen L; Becker JC; Andersen MH; Gjerdrum LMR; Litvinov IV; Litman T; Krejsgaard T; Woetmann A; Ødum N
    Blood Cancer J; 2020 May; 10(5):57. PubMed ID: 32409671
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation.
    Kim R; Boissel N; Touzart A; Leguay T; Thonier F; Thomas X; Raffoux E; Huguet F; Villarese P; Fourrage C; Passini L; Hunault M; Lepretre S; Chevallier P; Braun T; Lhéritier V; Chantepie S; Maury S; Escoffre M; Tavernier E; Chalandon Y; Graux C; Macintyre E; Ifrah N; Asnafi V; Dombret H; Lhermitte L;
    Leukemia; 2020 Jul; 34(7):1730-1740. PubMed ID: 31992840
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America.
    Montes-Mojarro IA; Chen BJ; Ramirez-Ibarguen AF; Quezada-Fiallos CM; Pérez-Báez WB; Dueñas D; Casavilca-Zambrano S; Ortiz-Mayor M; Rojas-Bilbao E; García-Rivello H; Metrebian MF; Narbaitz M; Barrionuevo C; Lome-Maldonado C; Bonzheim I; Fend F; Steinhilber J; Quintanilla-Martinez L
    Mod Pathol; 2020 May; 33(5):781-791. PubMed ID: 31822801
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Interleukin-6 mediates resistance to PI3K-pathway-targeted therapy in lymphoma.
    Kim JH; Kim WS; Park C
    BMC Cancer; 2019 Oct; 19(1):936. PubMed ID: 31601188
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The Signal Transducer and Activator of Transcription 5B (stat5b) Gene Promotes Proliferation and Drug Resistance of Human Mantle Cell lymphoma Cells by Activating the Akt Signaling Pathway.
    Zhang W; Liang X; Gong Y; Xiao C; Guo B; Yang T
    Med Sci Monit; 2019 Apr; 25():2599-2608. PubMed ID: 30964854
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.